SUN PHARMACEUTICAL INDUSTRIES LTD (CIK: 0001197089) EDGAR, Information, Filings... CompaniesBIO.Com

SUN PHARMACEUTICAL INDUSTRIES LTD

Mailing address
17/B, MAHAL INDUSTRIAL ESTATE, MAHAKALI CAVES ROAD, ANDEHERI (EAST), K7, 400 093
Phone
01191228212128
State location
India
State of incorporation
N/A
Fiscal year end
March 31
SIC
2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
Filings
N/A

SUN PHARMACEUTICAL INDUSTRIES LTD (CIK: 0001197089) is an American company incorporated in the state of India. Head office is located at 17/B, MAHAL INDUSTRIAL ESTATE, MAHAKALI CAVES ROAD, ANDEHERI (EAST), India, 400 093. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. SUN PHARMACEUTICAL INDUSTRIES LTD is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by SUN PHARMACEUTICAL INDUSTRIES LTD

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001193125-24-166301 ( Act) Size: KB	Jun-24-2024
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000950103-24-000736 ( Act) Size: KB	Jan-17-2024
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000950103-23-017375 ( Act) Size: KB	Dec-11-2023
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000950103-23-007957 ( Act) Size: KB	May-26-2023
SC TO-T/A	Document	Amendment to Third party tender offer statement Acc-no: 0001193125-23-060807 ( Act) Size: KB	Mar-06-2023
SC TO-T/A	Document	Amendment to Third party tender offer statement Acc-no: 0001193125-23-048734 ( Act) Size: KB	Feb-24-2023
SC TO-T	Document	Third party tender offer statement Acc-no: 0001193125-23-022120 ( Act) Size: KB	Feb-02-2023
SC TO-C	Document	Written communication relating to an issuer or third party tender offer Acc-no: 0001193125-23-021678 ( Act) Size: KB	Feb-01-2023
SC TO-C	Document	Written communication relating to an issuer or third party tender offer Acc-no: 0001193125-23-020480 ( Act) Size: KB	Jan-31-2023
SC TO-C	Document	Written communication relating to an issuer or third party tender offer Acc-no: 0000950103-23-000746 ( Act) Size: KB	Jan-19-2023
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000947871-22-000951 ( Act) Size: KB	Sep-08-2022
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001104659-20-069253 ( Act) Size: KB	Jun-03-2020
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001104659-20-041157 ( Act) Size: KB	Mar-31-2020
SC 13D	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001144204-17-060942 ( Act) Size: KB	Nov-27-2017
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-17-027391 (34 Act) Size: 0 KB	Nov-24-2017	001-38293 171221619
SC TO-C	Document	Written communication relating to an issuer or third party tender offer Acc-no: 0000947871-15-000654 ( Act) Size: KB	Sep-15-2015
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000947871-13-000755 ( Act) Size: KB	Nov-27-2013
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000947871-13-000074 ( Act) Size: KB	Feb-08-2013
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001104659-12-086188 ( Act) Size: KB	Dec-26-2012
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001104659-12-078972 (34 Act) Size: 0 KB	Nov-19-2012	001-31533 121215521

Recent 20 filings. View all SUN PHARMACEUTICAL INDUSTRIES LTD filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

SUN PHARMACEUTICAL INDUSTRIES LTD overview
SUN PHARMACEUTICAL INDUSTRIES LTD job
SUN PHARMACEUTICAL INDUSTRIES LTD stock
SUN PHARMACEUTICAL INDUSTRIES LTD ownership
SUN PHARMACEUTICAL INDUSTRIES LTD CEO
SUN PHARMACEUTICAL INDUSTRIES LTD documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.